Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker CME
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Daniel G. Kaye Director | CME CME Group Inc. | Sale | 532 | $304.17 | $161.8K Sale | Form 4 ↗ |
| Nov 2, 2026 | Julie Winkler Sr MD Chief Commercial Officer | CME CME Group Inc. | Sale | 10,079 | $305.15 | $3.1M Sale | Form 4 ↗ |
| Nov 2, 2026 | Howard J. Siegel Director | CME CME Group Inc. | Sale | 2,000 | $303.00 | $606.0K Sale | Form 4 ↗ |
| Oct 27, 2026 | Sunil Cutinho Chief Information Officer | CME CME Group Inc. | Sale | 5,000 | $298.70 | $1.5M Sale | Form 4 ↗ |
| Oct 22, 2026 | Martin J. Gepsman Director | CME CME Group Inc. | Sale | 400 | $302.50 | $121.0K Sale | Form 4 ↗ |
| Sep 25, 2026 | William R. Shepard Director | CME CME Group Inc. | Buy | 293 | $268.76 | $78.6K Buy | Form 4 ↗ |
| Sep 14, 2026 | Elizabeth A. Cook Director | CME CME Group Inc. | Sale | 500 | $280.11 | $140.1K Sale | Form 4 ↗ |
| Sep 10, 2026 | Terrence A. Duffy Chairman and CEO, Director | CME CME Group Inc. | Sale | 628 | $275.03 | $172.7K Sale | Form 4 ↗ |
| Sep 10, 2026 | Terrence A. Duffy Chairman and CEO, Director | CME CME Group Inc. | Sale | 14,372 | $274.41 | $3.9M Sale | Form 4 ↗ |
| Jun 25, 2026 | William R. Shepard Director | CME CME Group Inc. | Buy | 325 | $230.57 | $74.9K Buy | Form 4 ↗ |
| Jun 25, 2026 | William R. Shepard Director | CME CME Group Inc. | Buy | 14 | $230.57 | $3,302 Buy | Form 4 ↗ |
| May 18, 2026 | Hilda Harris Piell Sr MD & Chief HR Officer | CME CME Group Inc. | Sale | 5,753 | $304.63 | $1.8M Sale | Form 4 ↗ |
| May 15, 2026 | Terrence A. Duffy Chairman and CEO, Director | CME CME Group Inc. | Sale | 9,004 | $299.58 | $2.7M Sale | Form 4 ↗ |
| May 15, 2026 | Terrence A. Duffy Chairman and CEO, Director | CME CME Group Inc. | Sale | 25,996 | $298.14 | $7.8M Sale | Form 4 ↗ |
| Mar 26, 2026 | William R. Shepard Director | CME CME Group Inc. | Buy | 62 | $297.38 | $18.5K Buy | Form 4 ↗ |
| Mar 26, 2026 | William R. Shepard Director | CME CME Group Inc. | Buy | 1,408 | $297.38 | $418.6K Buy | Form 4 ↗ |
| Mar 17, 2026 | Jonathan L. Marcus Sr MD General Counsel | CME CME Group Inc. | Sale | 3,291 | $313.37 | $1.0M Sale | Form 4/A ↗ |
| Mar 12, 2026 | Ken Vroman Chief Transformation Officer | CME CME Group Inc. | Sale | 5,160 | $309.00 | $1.6M Sale | Form 4 ↗ |
| Mar 6, 2026 | Elizabeth A. Cook Director | CME CME Group Inc. | Sale | 1,000 | $320.00 | $320.0K Sale | Form 4 ↗ |
| Feb 23, 2026 | Bryan T. Durkin Director | CME CME Group Inc. | Sale | 4,200 | $309.65 | $1.3M Sale | Form 4 ↗ |
| Feb 20, 2026 | Martin J. Gepsman Director | CME CME Group Inc. | Sale | 300 | $305.90 | $91.8K Sale | Form 4 ↗ |
| Feb 6, 2026 | Dennis Suskind Director | CME CME Group Inc. | Sale | 748 | $300.00 | $224.4K Sale | Form 4 ↗ |
| Dec 30, 2025 | William R. Shepard Director | CME CME Group Inc. | Buy | 251 | $278.37 | $69.9K Buy | Form 4 ↗ |
| Dec 30, 2025 | William R. Shepard Director | CME CME Group Inc. | Buy | 11 | $278.37 | $3,079 Buy | Form 4 ↗ |
| Dec 11, 2025 | Terrence A. Duffy Chairman and CEO, Director | CME CME Group Inc. | Sale | 11,911 | $270.05 | $3.2M Sale | Form 4 ↗ |
| Dec 11, 2025 | Terrence A. Duffy Chairman and CEO, Director | CME CME Group Inc. | Sale | 13,089 | $269.10 | $3.5M Sale | Form 4 ↗ |
| Nov 20, 2025 | Derek Sammann Sr MD Gl Hd Commodities Mkts | CME CME Group Inc. | Sale | 1,314 | $275.74 | $362.3K Sale | Form 4 ↗ |
| Nov 20, 2025 | Derek Sammann Sr MD Gl Hd Commodities Mkts | CME CME Group Inc. | Sale | 5,886 | $275.65 | $1.6M Sale | Form 4 ↗ |
| Nov 3, 2025 | Harold Eugene Ford Jr. Director | CME CME Group Inc. | Sale | 1,000 | $263.53 | $263.5K Sale | Form 4 ↗ |
| Sep 25, 2025 | William R. Shepard Director | CME CME Group Inc. | Buy | 12 | $265.22 | $3,069 Buy | Form 4 ↗ |
| Sep 25, 2025 | William R. Shepard Director | CME CME Group Inc. | Buy | 262 | $265.19 | $69.6K Buy | Form 4 ↗ |
| Sep 18, 2025 | Jonathan L. Marcus Sr MD General Counsel | CME CME Group Inc. | Sale | 392 | $262.00 | $102.7K Sale | Form 4 ↗ |
| Sep 16, 2025 | Jonathan L. Marcus Sr MD General Counsel | CME CME Group Inc. | Sale | 376 | $258.96 | $97.4K Sale | Form 4 ↗ |
| Sep 16, 2025 | Timothy Francis McCourt Sr MD Global Head Equity & FX | CME CME Group Inc. | Sale | 379 | $259.83 | $98.5K Sale | Form 4 ↗ |
| Aug 26, 2025 | Sunil Cutinho Chief Information Officer | CME CME Group Inc. | Sale | 5,966 | $270.85 | $1.6M Sale | Form 4 ↗ |
| Aug 26, 2025 | Sunil Cutinho Chief Information Officer | CME CME Group Inc. | Sale | 5,930 | $272.10 | $1.6M Sale | Form 4 ↗ |
| Jun 25, 2025 | William R. Shepard Director | CME CME Group Inc. | Buy | 11 | $270.53 | $3,054 Buy | Form 4 ↗ |
| Jun 25, 2025 | William R. Shepard Director | CME CME Group Inc. | Buy | 256 | $270.53 | $69.3K Buy | Form 4 ↗ |
| Jun 10, 2025 | Charles P. Carey Director | CME CME Group Inc. | Sale | 350 | $265.35 | $92.9K Sale | Form 4 ↗ |
| Jun 10, 2025 | Charles P. Carey Director | CME CME Group Inc. | Sale | 150 | $265.36 | $39.8K Sale | Form 4 ↗ |
| May 22, 2025 | Daniel G. Kaye Director | CME CME Group Inc. | Sale | 500 | $282.42 | $141.2K Sale | Form 4 ↗ |
| May 20, 2025 | Jonathan L. Marcus Sr MD General Counsel | CME CME Group Inc. | Sale | 390 | $277.50 | $108.2K Sale | Form 4 ↗ |
| May 19, 2025 | Phyllis M. Lockett Director | CME CME Group Inc. | Sale | 1,060 | $277.88 | $294.6K Sale | Form 4 ↗ |
| May 15, 2025 | Martin J. Gepsman Director | CME CME Group Inc. | Sale | 300 | $273.17 | $82.0K Sale | Form 4 ↗ |
| May 15, 2025 | Charles P. Carey Director | CME CME Group Inc. | Sale | 3,000 | $272.56 | $817.7K Sale | Form 4 ↗ |
| May 5, 2025 | Derek Sammann Sr MD Gl Hd Commodities Mkts | CME CME Group Inc. | Sale | 2,475 | $280.60 | $694.5K Sale | Form 4 ↗ |
| May 5, 2025 | Derek Sammann Sr MD Gl Hd Commodities Mkts | CME CME Group Inc. | Sale | 2,175 | $280.63 | $610.4K Sale | Form 4 ↗ |
| Apr 29, 2025 | Dennis Suskind Director | CME CME Group Inc. | Sale | 1,000 | $271.28 | $271.3K Sale | Form 4 ↗ |
| Apr 25, 2025 | Larry G. Gerdes Director | CME CME Group Inc. | Sale | 2,000 | $266.12 | $532.2K Sale | Form 4 ↗ |
| Apr 24, 2025 | Larry G. Gerdes Director | CME CME Group Inc. | Sale | 1,000 | $265.10 | $265.1K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:27 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances